Speech-Language Pathologists in Independence, KY Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Mrs. Sharon Duvall Cross, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 749 Watersedge Dr, Independence, KY 41051 Phone: 859-363-1874

Widalys Borges Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 91 Fleming Dr, Independence, KY 41051 Phone: 513-550-7820

Mrs. Linda Catherine Payne, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1832 Forest Run Dr, Independence, KY 41051 Phone: 859-356-1155

Mrs. Kendra Leanne Stahl, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10801 Autumnridge Dr, Independence, KY 41051 Phone: 859-363-3739

Mrs. Catrina Marie Meredith Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1338 Hobart Ct, Independence, KY 41051 Phone: 513-658-5805    Fax: 859-554-4119

Emily Mary Braunwart Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11590 Tremont Ct, Independence, KY 41051 Phone: 859-630-1105

News Archive

Studies evaluate the impact of mobility restrictions during lockdown on air quality in urban areas

Two studies led by María Morales Suárez Varela, group leader of the CIBERESP at the University of Valencia and professor of the Department of Preventive Medicine and Public Health at the academic institution, have evaluated the impact of mobility restrictions on air quality and polluting emissions, in Valencia and in three Italian cities.

£126.5 million in disability benefits unclaimed

Macmillan Cancer Relief has announced that as much as £126.5 million in disability benefits is unclaimed by people diagnosed with terminal cancer in the UK.

Postmenopausal women undergoing combination hormone therapy at increased risk of heart disease: WHI confirms

New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman's risk of heart disease more than doubles within the first two years of taking combination HT.

Researchers reveal ethical and social issues faced by healthcare workers during the pandemic

In the early stages of the COVID-19 pandemic, while many of us remained in the safety of our own homes, frontline healthcare workers faced a sudden influx of patients with the new, highly contagious, life-threatening disease.

Improper cellular cleanup during neurodevelopment may cause lifelong behavioral issues

Improper removal of faulty brain cells during neurodevelopment may cause lifelong behavioral issues, new research from the University of Virginia School of Medicine suggests.

Read more Medical News

› Verified 6 days ago